The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
http://www.medicalnewstoday.com/releases/260941.php
http://www.medicalnewstoday.com/releases/260941.php